Brief: Atara Biotherapeutics Q1 EPS USD -0.23
09/05/2024 21:01
May 09 (Reuters) - Atara Biotherapeutics Q1 net income USD -31.752 million. * Q1 revenue USD 27.357 million * Q1 operating income USD -31.247 million
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM